PTH: A new target in arteriosclerosis?

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 10, 2013, Pages

  Buizert, Petra J ^a   Van Schoor, Natasja M ^a   Simsek, Suat ^a,b   Lips, Paul ^a   Heijboer, A C ^a   Den Heijer, M ^a   Deeg, Dorly J H ^a   Eekhoff, Elisabeth M W ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Medical Centre Alkmaar   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; PARATHYROID HORMONE;

ABDOMINAL AORTA; ABDOMINAL AORTIC CALCIFICATION; ADULT; AGE; AGED; ARTERIOSCLEROSIS; ARTERY CALCIFICATION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL;

EID: 84885232058     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-1621     Document Type: Article

References (40)

1. Walker MD, Silverberg SJ Cardiovascular aspects of primary hyperparathyroidism. J Endocrinol Invest. 2008; 31(10): 925-931.
2. Walker MD, Fleischer J, Rundek T., et al Carotid vascular abnormalities in primary hyperparathyroidism. J Clin Endocrinol Metab. 2009; 94(10): 3849-3856.
3. Saleh FN, Schirmer H, Sundsfjord J., Jorde R. Parathyroid hormone and left ventricular hypertrophy. Eur Heart J. 2003; 24(22): 2054-2060.
4. Rashid G, Bernheim J, Green J., Benchetrit S. Parathyroid hormone stimulates endothelial expression of atherosclerotic parameters through proteinkinase pathways. AmJPhysiol RenalPhysiol. 2007; 292(4): F1215-F1218.
5. Perkovic V, Hewitson TD, Kelynack K.J., Martic M., Tait MG, Becker GJ. Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells. Kidney Blood Press Res. 2003; 26(1): 27-33.
6. Jorde R, Svartberg J, Sundsfjord J. Serum parathyroid hormone as a predictor of increaseinsystolic blood pressureinmen. J Hypertens. 2005; 23(9): 1639-1644.
7. Snijder MB, Lips P, Seidell J.C., et al Vitamin D status and parathyroid hormone levels in relation to blood pressure: a population-based study in older men and women. J Intern Med. 2007; 261(6): 558-565.
8. Taylor EN, Curhan GC, Forman JP Parathyroid hormone and the risk of incident hypertension. J Hypertens. 2008; 26(7): 1390-1394.
9. Nuzzo V, Tauchmanova L, Fonderico F., et al Increased intima-media thickness of the carotid artery wall, normal blood pressure profile and normal left ventricular mass in subjects with primary hyperparathyroidism. Eur J Endocrinol. 2002; 147(4): 453-459.
10. Rashid G, Bernheim J, Green J., Benchetrit S. Parathyroid hormone stimulates the endothelial nitric oxide synthase through protein kinase A and C pathways. Nephrol Dial Transplant. 2007; 22(10): 2831-2837.
11. Hagstrom E, Hellman P, Larsson T.E., et al Plasma parathyroid hormone and the risk of cardiovascular mortality inthe community. Circulation. 2009; 119(21): 2765-2771.
12. Kamycheva E, Sundsfjord J, Jorde R. Serum parathyroid hormone levels predict coronary heart disease: the Tromso Study. Eur J Cardiovasc Prev Rehabil. 2004; 11(1): 69-74.
13. Choi HS, Kim SH, Rhee Y, Cho M.A., Lee EJ, Lim SK Serum parathyroid hormone is associated with carotid intima-media thickness in postmenopausal women. Int J Clin Pract. 2008; 62(9): 1352-1357.
14. Reis JP, von MD, Michos E.D., et al Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis. 2009; 207(2): 585-590.
15. Melamed ML, Muntner P, Michos E.D., et al Serum 25-hydroxyvitamin D levels and the prevalence of peripheral arterial disease: results from NHANES 2001 to 2004. Arterioscler Thromb Vasc Biol. 2008; 28(6): 1179-1185.
16. Huisman M, Poppelaars J, van der HM, et al Cohort profile: the Longitudinal Aging Study Amsterdam. Int JEpidemiol. 2011; 40(4): 868-876.
17. Kauppila LI, Polak JF, Cupples L.A., Hannan MT, Kiel DP, Wilson PW New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis. 1997; 132(2): 245-250.
18. Garretsen HFL, Kribbe RA Alcohol prevalentie onderzoek Rotterdam/Limburg, Landelijk Eindrapport, Ministerie van Welzijn, Volksgezondheid en Cultuur. Leidschendam. 1983.
19. Cockcroft DW, Gault MH Prediction of creatinine clearance from serum creatinine. Nephron. 1976; 16(1): 31-41.
20. Rennenberg RJ, Kessels AG, Schurgers L.J., van Engelshoven JM, de Leeuw PW, Kroon AA Vascular calcifications as a marker of increased cardiovascular risk: a meta-analysis. Vasc Health Risk Manag. 2009; 5(1): 185-197.
21. Pilz S, Tomaschitz A, Drechsler C., et al Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J.2010; 31(13): 1591-1598.
22. Bjorkman MP, Sorva AJ, Tilvis RS Elevated serum parathyroid hormone predicts impaired survival prognosisin ageneral aged population. Eur J Endocrinol. 2008; 158(5): 749-753.
23. Anderson JL, Vanwoerkom RC, Horne B.D., et al Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors? Am Heart J. 2011; 162(2): 331-339.
24. Schierbeck LL, Jensen TS, Bang U, Jensen G., Kober L, Jensen JE Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. Eur JHeart Fail. 2011; 13(6): 626-632.
25. Bjorkman M, Sorva A, Tilvis R. Parathyroid hormoneasamortality predictor in frail aged inpatients. Gerontology. 2009; 55(6): 601-606.
26. Sambrook PN, Chen JS, March L.M., et al Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin D status, bone mass, and renal function in the frail and very old: a cohort study. J Clin Endocrinol Metab. 2004; 89(11): 5477-5481.
27. Tomaschitz A, Ritz E, Pieske B., et al Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardio-vasc Res. 2012; 94(1): 10-19.
28. Edelmann F, Tomaschitz A, Wachter R., et al. Serumaldosterone and its relationship to left ventricular structure and geometry in patients with preserved left ventricular ejection fraction. Eur Heart J. 2012; 33(2): 203-212.
29. Schoppet M, Hofbauer LC, Brinskelle-Schmal N, et al Serum level of the phosphaturic factor FGF23 is associated with abdominal aortic calcification in men: the STRAMBO study. J Clin Endocrinol Metab. 2012; 97(4): E575-E583.
30. Pilz S, Tomaschitz A, Marz W., et al Vitamin D, cardiovascular disease and mortality. Clin Endocrinol (Oxf). 2011; 75(5): 575-584.
31. Wang L, Manson JE, Song Y, Sesso HD Systematic review: vitamin D and calcium supplementation in prevention of cardiovascular events. Ann Intern Med. 2010; 152(5): 315-323.
32. Kilkkinen A, Knekt P, Aro A., et al Vitamin D status and the risk of cardiovascular disease death. Am J Epidemiol. 2009; 170(8): 1032-1039.
33. Ginde AA, Scragg R, Schwartz R.S., Camargo CA Jr. Prospective study of serum 25-hydroxyvitamin D level, cardiovascular disease mortality, and all-cause mortality in older US adults. J Am Geriatr Soc. 2009; 57(9): 1595-1603.
34. Dobnig H, Pilz S, Scharnagl H., et al Independent association of low serum 25-hydroxyvitamin d and 1, 25-dihydroxyvitamin D levels with all-causeand cardiovascular mortality. Arch InternMed. 2008; 168(12): 1340-1349.
35. Messenger W, Nielson CM, Li H, et al Serum and dietary vitamin D and cardiovascular disease risk in elderly men: a prospective cohort study. Nutr Metab Cardiovasc Dis. 2012; 22(10): 856-863.
36. Jassal SK, Chonchol M, von M.D., Smits G., Barrett-Connor E. Vitamin D, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med. 2010; 123(12): 1114-1120.
37. Fiscella K, Franks P. Vitamin D, race, and cardiovascular mortality: findings from a national US sample. Ann Fam Med. 2010; 8(1): 11-18.
38. Welsh P, Doolin O, McConnachie A., et al Circulating 25OHD, dietary vitamin D, PTH, and calcium associations with incident cardiovascular disease and mortality: the MIDSPAN Family Study. J Clin Endocrinol Metab. 2012; 97(12): 4578-4587.
39. Chen JS, Sambrook PN, March L, et al Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf). 2008; 68(2): 290-298.
40. Rejnmark L, Vestergaard P, Heickendorff L., Andreasen F, Mosekilde L. Effects of thiazide- and loop-diuretics, alone or in combination, on calcitropic hormones and biochemical bone markers: arandomized controlledstudy. J Intern Med.2001; 250(2): 144-153.